15 Frequently Asked Questions : Bone Marrow Transplant Treatment in India for Uzbek Patients

Q1 · What is Bone Marrow Transplant Treatment?

Bone marrow transplantation is a procedure in which blood-forming stem cells are infused into a patient after conditioning treatment. These stem cells can restore blood-cell production after intensive chemotherapy or other treatments.

Although the term "bone marrow transplant" is commonly used, stem cells may be collected from

• Peripheral blood
• Bone marrow
• Umbilical cord blood

Peripheral blood stem-cell collection through apheresis is commonly used for many transplants.

Autologous Stem Cell Transplant

In an autologous transplant, the patient's own stem cells are collected and stored before high-dose treatment. They are then returned to the patient after conditioning therapy.

It may be used for selected

• Multiple myeloma
• Lymphomas
• Other diseases where high-dose therapy followed by autologous stem-cell rescue is appropriate

Allogeneic Stem Cell Transplant

In an allogeneic transplant, stem cells come from another person.

The donor may be

• Fully matched related donor
• Matched unrelated donor
• Haploidentical donor
• Another suitable donor source

Allogeneic transplantation may be used for selected

• Acute leukemia
• Aplastic anemia
• Myelodysplastic syndromes
• Myelofibrosis
• Thalassemia
• Certain inherited disorders
• Other high-risk blood disorders

The choice between autologous and allogeneic transplantation depends on the patient's specific disease and clinical circumstances.

Q2 · How much does Bone Marrow Transplant Treatment cost in Uzbekistan compared with India?

The cost depends on

• Type of transplant
• Disease being treated
• Autologous or allogeneic transplant
• Donor availability
• Donor matching
• Conditioning regimen
• Stem-cell collection
• Hospitalisation
• ICU requirements
• Infection treatment
• Blood and platelet transfusions
• Medicines
• Graft-versus-host disease management
• Post-transplant monitoring

For indicative planning, this guide uses

• US$1 ≈ UZS 12,200
• US$1 ≈ INR 96

These figures are indicative planning estimates. Actual costs can vary significantly according to diagnosis, transplant protocol, donor requirements, medicines and complications.

The quotation should clearly state whether it includes

• Recipient evaluation
• Donor evaluation
• HLA testing
• Crossmatching
• Stem-cell collection
• Stem-cell processing
• Conditioning chemotherapy
• Transplant infusion
• ICU
• Hospitalisation
• Blood products
• Anti-infective medicines
• Immunosuppressive medicines
• Management of complications
• Follow-up testing

Long-term medicines and follow-up after returning to Uzbekistan may be additional expenses.

Q3 · Which Indian cities can Uzbek patients consider for Bone Marrow Transplant Treatment?

Patients should specifically confirm that the selected centre has an active BMT programme suitable for their disease and transplant type. India has an established network of stem-cell transplant centres, and the Indian Society for Blood and Marrow Transplantation maintains a national transplant registry.

Q4 · Which hospitals in India can Uzbek patients consider for Bone Marrow Transplant Treatment?

Not every hospital listed provides every type of bone marrow or stem-cell transplant. Uzbek patients should specifically confirm the availability of

• Autologous BMT
• Allogeneic BMT
• Haploidentical transplantation
• Paediatric transplantation where required
• Cellular therapy where required
• HLA laboratory support
• Dedicated transplant units
• Blood-bank support
• Infection-control facilities

Current Indian transplant programmes document the use of autologous and allogeneic transplantation for different blood cancers and non-malignant disorders.

Q5 · What types of Bone Marrow Transplant Treatment are available?

1. Autologous Stem Cell Transplant

The patient's own stem cells are collected, stored and returned after high-dose treatment.

It is commonly considered for selected

• Multiple myeloma
• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Other appropriate diseases

2. Allogeneic Stem Cell Transplant

Stem cells are obtained from another person.

Possible donors include

• Matched sibling
• Matched related donor
• Matched unrelated donor
• Haploidentical family donor
• Other suitable donor sources

3. Haploidentical Transplant

A partially matched family donor may be used when a fully matched donor is unavailable or unsuitable.

4. Cord Blood Transplant

Umbilical cord blood can provide hematopoietic stem cells for selected patients.

5. Paediatric Bone Marrow Transplant

Children with leukemia, thalassemia, aplastic anemia, inherited disorders or other suitable conditions may undergo specialised transplantation.

6. Transplant for Blood Cancers

BMT may be considered for selected

• AML
• ALL
• CML
• Myelodysplastic syndromes
• Myelofibrosis
• Lymphomas
• Multiple myeloma

7. Transplant for Non-Malignant Disorders

Selected patients with

• Aplastic anemia
• Thalassemia
• Sickle-cell disease
• Inherited bone-marrow failure
• Certain immune disorders

may be considered for transplantation. The appropriate transplant type depends on the individual disease and patient characteristics.

Q6 · Who may be suitable for Bone Marrow Transplant Treatment?

Suitability depends on

• Exact diagnosis
• Disease stage
• Disease risk
• Genetic and molecular findings
• Previous treatment
• Response to treatment
• Relapse status
• Age
• General health
• Heart function
• Lung function
• Kidney function
• Liver function
• Infection status
• Donor availability

Patients with Blood Cancer

Transplant may be considered when

• Disease has high-risk features
• Disease has relapsed
• Disease has not responded adequately to standard treatment
• Transplant is expected to reduce the risk of recurrence
• The patient is medically fit enough for transplantation

Patients with Non-Malignant Disorders

Selected patients with severe aplastic anemia, thalassemia, inherited bone-marrow failure and certain immune disorders may be candidates.

Donor Considerations

For allogeneic transplantation, the team evaluates

• HLA compatibility
• Donor health
• Donor age
• Blood group
• Infectious-disease status
• Donor-specific factors

A suitable donor is important, but the absence of a fully matched sibling does not necessarily exclude transplantation because alternative donor strategies may be available.

Q7 · What tests are required before Bone Marrow Transplant Treatment?

The exact tests depend on the disease and transplant type.

Disease Evaluation

Patients may require

• Complete blood count
• Peripheral smear
• Bone-marrow aspiration
• Bone-marrow biopsy
• Flow cytometry
• Cytogenetics
• Molecular testing
• Immunohistochemistry
• PET-CT
• CT
• MRI where appropriate
• Minimal residual disease testing where appropriate

General Medical Assessment

The patient may undergo

• Kidney-function testing
• Liver-function testing
• ECG
• Echocardiogram
• Pulmonary-function testing
• Infection screening
• Viral testing
• Dental assessment
• Nutritional assessment

Donor Evaluation

A donor may require

• HLA typing
• Blood-group testing
• Complete blood count
• Kidney-function tests
• Liver-function tests
• Infectious-disease screening
• Medical examination
• Additional donor-specific investigations

The purpose is to ensure that transplantation is medically appropriate and that donor and recipient risks are adequately assessed.

Q8 · What medical records should Uzbek patients send before travelling?

Patients should provide

• Complete blood-count reports
• Peripheral blood-smear reports
• Bone-marrow aspiration reports
• Bone-marrow biopsy reports
• Flow-cytometry reports
• Cytogenetic reports
• Molecular genetic reports
• Immunohistochemistry
• PET-CT reports
• CT/MRI reports
• Minimal residual disease results where available
• Previous pathology reports
• Previous chemotherapy records
• Previous radiation records
• Previous transplant records
• Current medication list
• Blood-transfusion history
• Infection history
• Hospital discharge summaries

Patients should also provide

• Exact diagnosis
• Disease subtype
• Disease stage or risk category
• Date of diagnosis
• Previous treatments
• Number of chemotherapy cycles
• Response to treatment
• Current disease status
• Relapse history
• Current blood counts
• Molecular abnormalities
• Previous transplant recommendations

Potential donors should provide available

• Blood group
• HLA information
• Medical history
• Previous surgery records
• Relevant laboratory reports

Original pathology reports and imaging files should be shared whenever possible.

Q9 · How does Bone Marrow Transplant Treatment work?

The transplant process generally includes several stages.

Step 1: Confirm the Diagnosis

The transplant team confirms the exact disease using blood, bone-marrow, pathology, molecular and imaging investigations.

Step 2: Assess Transplant Eligibility

The team evaluates

• Disease risk
• Previous treatment
• Response
• Organ function
• Infection status
• General fitness

Step 3: Identify the Stem-Cell Source

For autologous transplantation, the patient's own stem cells are collected.

For allogeneic transplantation, a suitable donor is identified.

Step 4: Stem-Cell Collection

Stem cells may be collected from

• Peripheral blood
• Bone marrow
• Cord blood

Peripheral blood stem-cell collection is commonly performed using apheresis.

Step 5: Conditioning Treatment

The patient receives chemotherapy, with or without radiation, to prepare the body for transplantation.

The conditioning regimen depends on the disease and transplant type.

Step 6: Stem-Cell Infusion

The collected stem cells are infused into the patient through an intravenous line.

The infusion itself does not normally require major surgery or an operation.

Step 7: Engraftment

The transplanted stem cells begin producing new blood cells.

The patient remains under close monitoring during this period because blood counts are initially very low and infection risk can be significant.

Step 8: Post-Transplant Care

The team monitors

• Blood counts
• Infection
• Kidney function
• Liver function
• Graft function
• Medication effects
• Graft-versus-host disease after allogeneic transplant

Step 9: Long-Term Follow-Up

Patients require ongoing monitoring for

• Disease recurrence
• Immune recovery
• Infections
• Organ complications
• Late treatment effects

Q10 · What are the alternatives to Bone Marrow Transplant Treatment?

BMT is not appropriate for every patient.

Depending on the disease, alternatives may include

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• CAR-T cell therapy
• Antibody-based therapy
• Maintenance treatment
• Supportive treatment
• Blood transfusions
• Immunosuppressive therapy
• Disease-specific medicines
• Clinical trials

For example, some patients with leukemia may be treated with targeted medicines or chemotherapy without transplantation. Selected lymphoma patients may receive chemotherapy, immunotherapy or cellular therapy. Patients with aplastic anemia may receive immunosuppressive treatment when transplantation is not appropriate. The choice depends on the exact disease, treatment response and individual risk.

Q11 · What should Uzbek patients ask before accepting a Bone Marrow Transplant quotation?

Patients should ask

• What is the exact diagnosis?
• What is the exact disease subtype?
• What is the current disease status?
• Why is transplantation being recommended?
• Is transplantation urgent?
• Is autologous transplantation appropriate?
• Is allogeneic transplantation required?
• Is a donor available?
• Is HLA matching complete?
• Is a haploidentical donor being considered?
• What donor testing is required?
• What conditioning regimen will be used?
• How will stem cells be collected?
• Will stem cells come from blood or bone marrow?
• How long will stem-cell collection take?
• How long will conditioning take?
• How long is the expected transplant admission?
• How long until engraftment?
• Will ICU care be required?
• What are the major transplant risks?
• What is the risk of infection?
• What is the risk of graft-versus-host disease?
• What is the risk of graft failure?
• Will blood and platelet transfusions be required?
• What medicines will be required?
• Are immunosuppressive medicines included?
• Are donor expenses included?
• Are HLA and molecular tests included?
• Are ICU charges included?
• Are infection-treatment costs included?
• What costs are excluded?
• How long should the patient stay in India?
• When can the patient safely return to Uzbekistan?
• How will follow-up be managed after returning home?
• What medical records will be provided at discharge?

Patients should request a detailed written quotation with clear included and excluded items.

Q12 · How long should Uzbek patients stay in India for Bone Marrow Transplant Treatment?

Bone marrow transplantation generally requires a substantially longer stay than routine surgery.

The treatment journey may include

• Initial specialist consultation
• Diagnostic review
• Bone-marrow evaluation
• Molecular testing
• Donor evaluation
• HLA testing
• Pre-transplant investigations
• Stem-cell collection
• Conditioning treatment
• Stem-cell infusion
• Engraftment monitoring
• Infection management
• Early post-transplant follow-up

The initial transplant admission may commonly extend for approximately 3–5 weeks, depending on the disease and transplant type. The overall international-patient stay may be approximately 6–12 weeks or longer, especially for allogeneic transplantation.

Some patients may require an even longer stay because of

• Delayed engraftment
• Infection
• Graft-versus-host disease
• Organ complications
• Other transplant-related problems

Patients should not book a fixed return flight until the transplant team confirms that travel is medically appropriate.

Q13 · What is recovery like after Bone Marrow Transplant Treatment?

Recovery after BMT is gradual and may continue for months.

During the early period, patients may experience

• Fatigue
• Weakness
• Low blood counts
• Fever
• Increased infection risk
• Nausea
• Vomiting
• Mouth ulcers
• Reduced appetite
• Weight loss
• Hair loss

Patients may require

• Blood transfusions
• Platelet transfusions
• Antibiotics
• Antiviral medicines
• Antifungal medicines
• Nutritional support
• Immunosuppressive medicines after allogeneic transplantation

Graft-Versus-Host Disease

After allogeneic transplantation, donor immune cells may attack the patient's tissues. This is called graft-versus-host disease.

It can affect organs such as

• Skin
• Liver
• Gastrointestinal tract
• Other tissues

The transplant team monitors for this complication and may prescribe medicines to prevent or treat it.

Seek urgent medical attention for:

• Fever
• Chills
• Difficulty breathing
• Severe diarrhoea
• Persistent vomiting
• Skin rash
• Yellowing of the eyes or skin
• Unusual bleeding
• Severe abdominal pain
• Confusion
• New neurological symptoms
• Sudden deterioration

Patients should follow the transplant centre's infection-prevention instructions carefully.

Q14 · How can follow-up be managed after returning to Uzbekistan?

Before leaving India, patients should obtain

• Complete transplant summary
• Final diagnosis
• Bone-marrow reports
• Molecular reports
• HLA reports
• Donor information where appropriate
• Stem-cell collection information
• Conditioning regimen
• Transplant date
• Discharge summary
• Medication list
• Immunosuppressive treatment plan
• Infection-prevention instructions
• Follow-up schedule

Follow-up may include

• Complete blood counts
• Kidney-function tests
• Liver-function tests
• Bone-marrow examination
• Molecular testing
• Minimal residual disease testing
• Chimerism testing after allogeneic transplant where appropriate
• Imaging where required
• Drug-level monitoring
• Infection monitoring

Allogeneic transplant recipients require monitoring for graft-versus-host disease and other transplant-related complications. Patients should establish follow-up with a qualified hematologist or transplant physician in Uzbekistan. They should inform all healthcare providers about their transplant because medicines and infections can have special implications after transplantation.

Q15 · Should an Uzbek patient travel to India for Bone Marrow Transplant Treatment?

Uzbek patients considering BMT in India should first have their complete hematology records reviewed by an experienced transplant team.

Before travelling, patients should understand

• Exact blood disorder or blood cancer
• Disease subtype
• Current disease status
• Previous treatment
• Treatment response
• Reason transplantation is recommended
• Type of transplant required
• Whether an autologous transplant is appropriate
• Whether an allogeneic transplant is required
• Donor availability
• HLA compatibility
• Need for conditioning treatment
• Expected transplant admission
• Expected India stay
• Estimated cost
• Possible complications
• Infection risks
• Graft-versus-host disease risk
• Follow-up requirements

BMT is a highly specialised treatment requiring dedicated infrastructure and experienced transplant teams. India's national guidance describes hematopoietic cell transplantation as a complex and highly specialised therapy requiring appropriate infrastructure and trained teams. Patients should obtain a clear written transplant plan and detailed quotation before finalising travel arrangements.